These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 31982106

  • 1. Comparison of 68Ga-Dotatate PET/CT and 18F-FDOPA PET/CT for the diagnosis of pancreatic neuroendocrine tumors in a MEN1 patient.
    Jullien M, Reichert T, D'Anella P, Castinetti F, Barlier A, Brue T, Taieb D, Cuny T.
    Ann Endocrinol (Paris); 2020 Feb; 81(1):39-43. PubMed ID: 31982106
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of (68)Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1.
    Morgat C, Vélayoudom-Céphise FL, Schwartz P, Guyot M, Gaye D, Vimont D, Schulz J, Mazère J, Nunes ML, Smith D, Hindié E, Fernandez P, Tabarin A.
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1258-66. PubMed ID: 26819103
    [Abstract] [Full Text] [Related]

  • 3. Carbidopa-assisted 18F-fluorodihydroxyphenylalanine PET/CT for the localization and staging of non-functioning neuroendocrine pancreatic tumors.
    Helali M, Addeo P, Heimburger C, Detour J, Goichot B, Bachellier P, Namer IJ, Taïeb D, Imperiale A.
    Ann Nucl Med; 2016 Nov; 30(9):659-668. PubMed ID: 27485404
    [Abstract] [Full Text] [Related]

  • 4. Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).
    Lastoria S, Marciello F, Faggiano A, Aloj L, Caracò C, Aurilio M, D'Ambrosio L, Di Gennaro F, Ramundo V, Camera L, De Luca L, Fonti R, Napolitano V, Colao A.
    Endocrine; 2016 Jun; 52(3):488-94. PubMed ID: 26242621
    [Abstract] [Full Text] [Related]

  • 5. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.
    Archier A, Varoquaux A, Garrigue P, Montava M, Guerin C, Gabriel S, Beschmout E, Morange I, Fakhry N, Castinetti F, Sebag F, Barlier A, Loundou A, Guillet B, Pacak K, Taïeb D.
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1248-57. PubMed ID: 26637204
    [Abstract] [Full Text] [Related]

  • 6. 68Ga-DOTATATE PET/CT imaging for insulinoma in MEN1 patient with endogenous hyperinsulinemic hypoglycemia: A case report.
    Liu Y, Zhao X, Zhang J, Wang J, Zhang Z, Dai M, Wang N, Jing F, Wang T, Tian W.
    Medicine (Baltimore); 2022 Aug 26; 101(34):e30252. PubMed ID: 36042606
    [Abstract] [Full Text] [Related]

  • 7. Heterogeneity of Multiple Pancreatic Neuroendocrine Tumors Identified by 68Ga-DOTANOC and 68Ga-Exendin-4 PET/CT in a Patient with Endogenous Hyperinsulinemic Hypoglycemia and Multiple Endocrine Neoplasia 1.
    Xu J, Xu X, Zhang M, Liu W, Chen J, Song S.
    Neuroendocrinology; 2024 Aug 26; 114(9):866-871. PubMed ID: 38471465
    [Abstract] [Full Text] [Related]

  • 8. Utility of FDG-PET Imaging for Risk Stratification of Pancreatic Neuroendocrine Tumors in MEN1.
    Kornaczewski Jackson ER, Pointon OP, Bohmer R, Burgess JR.
    J Clin Endocrinol Metab; 2017 Jun 01; 102(6):1926-1933. PubMed ID: 28323985
    [Abstract] [Full Text] [Related]

  • 9. 18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation.
    Imperiale A, Rust E, Gabriel S, Detour J, Goichot B, Duclos B, Kurtz JE, Bachellier P, Namer IJ, Taïeb D.
    J Nucl Med; 2014 Mar 01; 55(3):367-72. PubMed ID: 24343986
    [Abstract] [Full Text] [Related]

  • 10. Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests (CT, MRI, and PET/CT Using 68Ga-DOTATATE, FDG, 18F-FDOPA, and 18F-FDA).
    Jha A, Patel M, Carrasquillo JA, Ling A, Millo C, Saboury B, Chen CC, Wakim P, Gonzales MK, Meuter L, Knue M, Talvacchio S, Herscovitch P, Rivero JD, Chen AP, Nilubol N, Taïeb D, Lin FI, Civelek AC, Pacak K.
    AJR Am J Roentgenol; 2022 Feb 01; 218(2):342-350. PubMed ID: 34431366
    [Abstract] [Full Text] [Related]

  • 11. 68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI.
    Janssen I, Chen CC, Taieb D, Patronas NJ, Millo CM, Adams KT, Nambuba J, Herscovitch P, Sadowski SM, Fojo AT, Buchmann I, Kebebew E, Pacak K.
    J Nucl Med; 2016 Feb 01; 57(2):186-91. PubMed ID: 26564322
    [Abstract] [Full Text] [Related]

  • 12. Limited role of carbidopa-assisted 18F-FDOPA PET/CT in patients with sporadic non-functional gastroduodenal neuroendocrine neoplasms.
    Imperiale A, Averous G, Helali M, Taieb D, Pessaux P, Goichot B, Addeo P, Bachellier P.
    Ann Nucl Med; 2019 Sep 01; 33(9):697-707. PubMed ID: 31214959
    [Abstract] [Full Text] [Related]

  • 13. EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.
    van Asselt SJ, Brouwers AH, van Dullemen HM, van der Jagt EJ, Bongaerts AH, Kema IP, Koopmans KP, Valk GD, Timmers HJ, de Herder WW, Feelders RA, Fockens P, Sluiter WJ, de Vries EG, Links TP.
    Gastrointest Endosc; 2015 Jan 01; 81(1):159-167.e2. PubMed ID: 25527055
    [Abstract] [Full Text] [Related]

  • 14. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
    Sadowski SM, Neychev V, Millo C, Shih J, Nilubol N, Herscovitch P, Pacak K, Marx SJ, Kebebew E.
    J Clin Oncol; 2016 Feb 20; 34(6):588-96. PubMed ID: 26712231
    [Abstract] [Full Text] [Related]

  • 15. The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy.
    Srirajaskanthan R, Kayani I, Quigley AM, Soh J, Caplin ME, Bomanji J.
    J Nucl Med; 2010 Jun 20; 51(6):875-82. PubMed ID: 20484441
    [Abstract] [Full Text] [Related]

  • 16. 68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial.
    Etchebehere EC, de Oliveira Santos A, Gumz B, Vicente A, Hoff PG, Corradi G, Ichiki WA, de Almeida Filho JG, Cantoni S, Camargo EE, Costa FP.
    J Nucl Med; 2014 Oct 20; 55(10):1598-604. PubMed ID: 25168627
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Head-to-Head Comparison of 64Cu-DOTATATE and 68Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine Tumors.
    Johnbeck CB, Knigge U, Loft A, Berthelsen AK, Mortensen J, Oturai P, Langer SW, Elema DR, Kjaer A.
    J Nucl Med; 2017 Mar 20; 58(3):451-457. PubMed ID: 27660147
    [Abstract] [Full Text] [Related]

  • 19. Pancreatic imaging in MEN1-comparison of conventional and somatostatin receptor positron emission tomography/computed tomography imaging in real-life setting.
    Kostiainen I, Majala S, Schildt J, Parviainen H, Kauhanen S, Seppänen H, Miettinen PJ, Matikainen N, Ryhänen EM, Schalin-Jäntti C.
    Eur J Endocrinol; 2023 May 10; 188(5):421-429. PubMed ID: 36943311
    [Abstract] [Full Text] [Related]

  • 20. The utility of 68Gallium-DOTATATE PET/CT in the detection of von Hippel-Lindau disease associated tumors.
    Shell J, Tirosh A, Millo C, Sadowski SM, Assadipour Y, Green P, Patel D, Nilubol N, Kebebew E.
    Eur J Radiol; 2019 Mar 10; 112():130-135. PubMed ID: 30777201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.